Related Experiment Video
Updated: Jul 24, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
"One Blood Clot Is One Too Many": Affected Vocal Users' Negative Perspectives on Controversial Oral Contraceptives
11 Queen Mary University of London, London, United Kingdom.
Women using Yaz and Yasmin contraceptive pills reported negative side effects and inadequate risk information. They advocate for improved health risk communication and drug regulation, critiquing current risk assessment methods for hormonal contraceptives.
Area of Science:
- Pharmacology
- Public Health
- Sociology of Health
Background:
- The fourth generation of contraceptive pills, including Yaz and Yasmin, has faced controversy due to reported adverse effects.
- Understanding patient experiences is crucial for evaluating hormonal contraception safety and communication.
Purpose of the Study:
- To analyze women's negative experiences with Yaz and Yasmin.
- To explore how these experiences shape understanding of hormonal contraceptive risks.
- To identify needs for improved health risk communication and drug regulation.
Main Methods:
- In-depth interviews with 24 women in Canada who used Yaz or Yasmin.
- Qualitative analysis of reported deleterious side effects and risk perceptions.
Main Results:
- Interviewees reported inadequate risk information before starting the drugs.
- Participants questioned the use of pregnancy risks for contextualizing hormonal contraceptive risks.
- A critique of professional risk/benefit assessment procedures was evident.
Conclusions:
- Women's negative experiences highlight deficiencies in current risk communication for hormonal contraceptives.
- There is a need for enhanced patient-centered risk assessment and clearer regulatory frameworks for prescription drugs.
- Patient perspectives are vital for informing safer practices in reproductive health and drug regulation.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Birth Control Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...